New Synergistic Combination Therapy of Mupirocin and α-Pinene Against Multidrug-Resistant Clinical Strains of Methicillin-Resistant Staphylococcus aureus
- PMID: 38860960
New Synergistic Combination Therapy of Mupirocin and α-Pinene Against Multidrug-Resistant Clinical Strains of Methicillin-Resistant Staphylococcus aureus
Abstract
Objective: Increased mupirocin use leads to mupirocin resistance and is associated with persistence of methicillin-resistant Staphylococcus aureus (MRSA) carriers, prolonged hospitalization, and significant economic burdens for health systems. The study aimed to investigate the antimicrobial activity of compounds of Salvia rosmarinus L. ("rosemary", formerly Rosmarinus officinalis), alone or in combination with mupirocin, against multidrug resistant MRSA using isolates obtained from pediatric patients.
Methods: The in vitro antibacterial activity of the monoterpene α-pinene (α-Pi), a rosemary essential oil constituent, alone and in combination with mupirocin, was evaluated by determining the minimum inhibitory concentrations and minimum bactericidal concentrations (MBCs) and the fractional inhibitory concentration indices (FICIs) and fractional bactericidal concentration indices against multidrug-resistant clinical MRSA strains. The in vivo efficacy of α-Pi, alone and in combination with mupirocin, to eradicate MRSA infection was determined using an optimized mouse model of MRSA-infected wounds. Mouse skin samples (obtained via biopsy) were assessed for toxicity, and rabbit skin samples for irritation.
Results: Both in vitro and in vivo, α-Pi was active against MRSA strains and acted synergistically with mupirocin against MRSA strains. Mupirocin-monoterpene combinations exhibited FICI values of 0.2 to 0.4, reducing the MBC of topical mupirocin 33-fold. A topical formulation containing α-Pi and mupirocin enhanced the efficacy of mupirocin in an in vivo MRSA-infected mouse skin model without significantly harming the skin of mice and rabbits.
Conclusions: A topical formulation combining mupirocin and α-Pi may aid in the development of innovative agents for treating MRSA infections.
Keywords: Alpha-pinene; Drug synergism; Methicillin-resistant Staphylococcus aureus; Mupirocin; Skin.
Similar articles
-
Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model.PLoS One. 2015 Nov 4;10(11):e0142321. doi: 10.1371/journal.pone.0142321. eCollection 2015. PLoS One. 2015. PMID: 26536129 Free PMC article.
-
Carnosic acid acts synergistically with gentamicin in killing methicillin-resistant Staphylococcus aureus clinical isolates.Phytomedicine. 2016 Nov 15;23(12):1337-1343. doi: 10.1016/j.phymed.2016.07.010. Epub 2016 Jul 29. Phytomedicine. 2016. PMID: 27765353
-
[Investigation of antibacterial activity of topical antimicrobials against methicillin-resistant Staphylococcus aureus].Zhonghua Shao Shang Za Zhi. 2014 Feb;30(1):21-4. Zhonghua Shao Shang Za Zhi. 2014. PMID: 24684985 Chinese.
-
Clinical relevance of mupirocin resistance in Staphylococcus aureus.J Hosp Infect. 2013 Dec;85(4):249-56. doi: 10.1016/j.jhin.2013.09.006. Epub 2013 Sep 21. J Hosp Infect. 2013. PMID: 24144552 Review.
-
Review: the spectrum of antimicrobial resistance in bacteria isolated from wounds of patients with epidermolysis bullosa.J Dermatolog Treat. 2024 Dec;35(1):2370424. doi: 10.1080/09546634.2024.2370424. Epub 2024 Jun 27. J Dermatolog Treat. 2024. PMID: 38936964 Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous